India Allergy Diagnostics Market – Industry Trends and Forecast to 2029

시장 분석 및 규모

WHO(세계보건기구)에 따르면 전 세계 인구의 약 80%가 도시에 살고 있으며, 그 결과 대기 질이 도시에 상당한 영향을 미치고 있으며, 주로 저소득 국가에서 그렇습니다. 또한 여러 연구에서 대기 오염과 알레르기성 비염, 천식 및 기타 질환이 연관되어 알레르기 진단이 증가하고 있습니다. 알레르기는 신체의 거의 모든 장기에 영향을 미칠 수 있고 다양한 외부 원인에 의해 유발될 수 있지만, 연구 노력에서 강조해야 할 몇 가지 공통적인 주제가 있습니다. 효과적인 예방, 치유적 요법 및 정확하고 조기에 진단하는 것은 다른 많은 만성 질환과 마찬가지로 충족되지 않은 핵심 요구 사항입니다. 임상 증상을 보다 일관되고 일관되며 치료에 반응하는 그룹으로 구성하거나 재분류하기 위해서는 자세한 표현형/내형이 널리 필요합니다.

Data Bridge Market Research는 2021년에 42억 5천만 달러였던 인도 알레르기 진단 시장이 2029년까지 97억 2천만 달러로 급증할 것으로 분석했으며, 2022년부터 2029년까지 예측 기간 동안 10.9%의 CAGR을 보일 것으로 예상합니다. Data Bridge Market Research 팀이 큐레이팅한 시장 보고서에는 심층적인 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크가 포함되어 있습니다.

보고 범위 및 시장 세분화

시장 정의

알레르기는 신체의 거의 모든 장기에 다양한 방식으로 영향을 미치며, 증상의 범위가 넓기 때문에 그 증상은 광범위한 표현형에 걸쳐 있습니다. 유럽의 연구에 따르면, 인구의 최대 30%가 알레르기성 비강 결막염을 앓고 있으며, 20%는 천식을 앓고 있으며, 15%는 알레르기성 피부 질환을 앓고 있습니다. 식품 알레르기는 점점 더 흔해지고 심각해지고 있습니다. 직업성 알레르기, 약물 알레르기, 곤충 쏘임 알레르기(치명적일 수 있음)는 모두 알레르기 유행에 기여하고 있습니다.

인도 알레르기 진단 시장 역학

운전자

• 환경 오염 수준 증가

실내 및 실외 대기 오염, 알레르기 및 직업적 노출은 만성 호흡기 질환의 주요 위험 요소입니다. 알레르기 질환의 유병률은 도시에서 환경 오염 물질에 더 많이 노출되기 때문에(자동차 오염 및 산업 활동의 결과) 도시 거주자에게 농촌 거주자보다 높습니다. WHO에 따르면 도시에 거주하는 사람의 80% 이상이 WHO 안전 권장 사항을 초과하는 대기 질 수준에 노출되고 있으며, 이는 전 세계적인 추세이지만 저소득 국가의 도시 지역에서 그 영향이 특히 심각합니다. 이는 알레르기 진단 시장이 확대되고 있다는 주요 지표입니다.

• 증가하는 환경 오염 수준

성장의 주요 동인은 의료비 지출 증가, 평균 수명 증가, 예방 검사에 대한 이해 증가, 진단 검사 제공 개선, 생활 습관병 증가, 정부에서 의무화한 건강 관리 치료 등입니다.

• 건강보험 접근성 증가

The market is dominated by large hospitals and diagnostic laboratories, which can afford high-volume systems due to their large capital budgets. Rising healthcare expenditures aid the expansion of the allergy diagnostics market as a result of high healthcare service costs. In addition, governments in many countries are giving reimbursements and healthcare insurance programs to boost consumer demand for allergy diagnostics around the world.

Opportunities

• Use of m-Health technology in allergy diagnosis

Mobile Health tools for allergic rhinitis (AR) diagnosis published in peer-reviewed papers, the use of mHealth for rhinitis diagnosis is currently limited. A new breed of point-of-care devices has emerged as a result of recent advancements in integrated biosensors, wireless connectivity, and power harvesting techniques. AR, on the other hand, is a highly prevalent disease. Any diagnostic gadget connected to a smartphone (e.g., peak nasal inspiratory flow metres or intranasal biosensors) would have to be affordable.

Restraints/Challenges

• Difficulty in allergy diagnosis

The difficulty in allergy diagnosis is coming up with procedures that are objective, quick, repeatable, cost-effective, sensitive, and specific to the condition. They must be able to recognise exposures and contribute to therapeutic decision-making, preferably in primary care. In addition, tests to monitor therapy response and to compare preclinical and clinical effects across large cohorts and between nations are required.

• Premium costs associated with allergy diagnostic instruments

Market participants update several allergy diagnostic devices, including as luminometers, blot analyzers, scanners, ELISA analyzers, and immunoassay analyzers, on a regular basis. These instruments are more expensive since they have more advanced features and functions (the price of each instrument varies based on its accuracy, flexibility, and TAT). Immunoassay analyzers, for example, cost between USD 10,000 and USD 20,000, while luminometers cost between USD 3,000 and USD 14,000. ELISA readers that are semi-automated cost between USD 2,000 and USD 5,000, while fully automated analyzers cost over USD 14,000. In addition, operating this equipment necessitates extra costs such as maintenance and insurance, laboratory supervision, and overheads (such as utilities, space, and administration).

This India allergy diagnostics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the India allergy diagnostics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on India Allergy Diagnostics Market

COVID 19 has been the subject of several research to see how it affects allergy diagnostic testing services. According to a survey done in Turkey, allergists prefer to employ telemedicine for asthma and rhinitis during the COVID-19 outbreak at a high rate. However, face-to-face interviews were preferable for more severe allergic illnesses like anaphylaxis and hereditary angioedema. Other countries, such as Italy and the United States, have seen a similar trend. In Australia, face-to-face consultations in outpatient clinics were confined to urgent patients with rheumatological disorders, and roughly 80% of outpatient visits were switched to telemedicine. This also hampered the market's expansion by limiting the restriction and decrease of various diagnostic and treatment services.

Recent Development

• In 2021, Hitachi Chemical Diagnostics, Inc. has been replaced by Minaris Medical America, Inc. By uniting the medical business group firms under the Minaris Medical brand, Hitachi wants to boost its global position and increase commercial activities in the field of in-vitro diagnostics. Showa Denko Materials Co., Ltd own both companies.
• In 2021, PerkinElmer Inc. has reached an agreement to purchase Immunodiagnostic Systems Holdings PLC. PerkinElmer Inc. will be able to strengthen its position in the ImmunoDiagnostics (IDS) industry as a result of the acquisition. EUROIMMUN Medizinische LABORDIAGNOSTIKA AG, a firm that sells allergy products and services, will take over IDS.

India Allergy Diagnostics Market Scope

The India allergy diagnostics market is segmented on the basis of product, allergan, test, end-user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Products

• Assay Kits
• Consumables
• Instruments
• Immunoassay Analyzers
• ELISA Analyzers
• Luminometers
• Other Instruments
• Services

Allergen

• Inhaled Allergens
• Food Allergens
• Drug Allergens
• Other Allergens

Test

• In Vivo Tests
• Skin Prick Tests
• Patch Tests
• Other In Vivo Tests
• In Vitro Tests

End User

• Diagnostic Laboratories
• Hospital-based Laboratories
• Academic Research Institutes
• Other End Users

Distribution Channel

•  Direct
•  Indirect

India Allergy Diagnostics Market Regional Analysis/Insights

The India allergy diagnostics market is analysed and market size insights and trends are provided by country, product, allergan, test, end-user and distribution channel as referenced above.

The countries covered in the India allergy diagnostics market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the allergy diagnostics market due to rise in the incidence of respiratory allergic disorders. Furthermore, rising awareness of allergy diagnostics and the implementation of in vitro blood tests will propel the allergy diagnostics market in the area to new heights throughout the forecast period.

Asia-Pacific is expected to observe a substantial amount of growth in the allergy diagnostics market due to the rapid change in the improving of healthcare infrastructure. Furthermore, the region's allergy diagnostics market is expected to develop in the next years due to unmet clinical demands and an increasing need for minimally invasive diagnostic tools.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

The India allergy diagnostics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for India allergy diagnostics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the India allergy diagnostics market. The data is available for historic period 2010-2020.

Competitive Landscape and India Allergy Diagnostics Market Share Analysis

The India allergy diagnostics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to India allergy diagnostics market.

Some of the major players operating in the India allergy diagnostics market are:

• Thermo Fisher Scientific Inc., (US)
• Siemens Healthcare GmbH (Germany)
• Danaher (US)
• Omega Diagnostics Group PLC (UK)
• bioMérieux (France)
• Romer Labs Division Holding (Austria)
• EUROIMMUN Medizinische Labordiagnostika AG (Germany)
• HollisterStier Allergy (US)
• NEOGEN Corporation (US)
• Eurofins Scientific (Luxembourg)
• Minaris Medical America, Inc. (US)
• Stallergenes Greer (UK)
• HOB Biotech Group Corp., Ltd. (China)
• HYCOR Biomedical (US)
• R-Biopharm AG (Germany)
• AESKU.GROUP GmbH (Germany)
• ACON Laboratories, Inc. (US)
• Lincoln Diagnostics, Inc. (US)
• Astra Biotech GmbH (Germany)
• Erba Group (UK)

SKU-50717